Treatments for glioblastoma (IDH-wild type)

The following are treatments for glioblastoma. It is a grade 4 tumour, so it grows quickly and spreads deeply into the nearby brain tissue.

All glioblastomas are classified as glioblastoma (IDH-wild type).

Your healthcare team will suggest treatments based on your needs and work with you to develop a treatment plan.

Surgery

Surgery is usually the first treatment for glioblastoma. It is used to remove as much of the tumour as possible.

Surgery is followed by radiation therapy or chemotherapy or both.

Find out more about surgery for brain and spinal cord tumours.

Radiation therapy

Radiation therapy uses high-energy rays or particles to destroy cancer cells. Radiation therapy is used after surgery to treat the area where the tumour was removed and any cancer cells that may be left. Radiation therapy may also be used by itself as the main treatment if the tumour can’t be removed, or if you aren’t healthy enough or don’t want to have surgery.

Find out more about radiation therapy for brain and spinal cord tumours.

Chemotherapy

Chemotherapy uses drugs to destroy cancer cells. Chemotherapy is often used with radiation therapy after surgery to treat glioblastoma.

The most common chemotherapy drug used to treat glioblastoma is temozolomide. It is offered after surgery or if the tumour can’t be removed with surgery.

Carmustine implants may be placed at the end of surgery in the cavity in the brain where the tumour was removed.

Find out more about chemotherapy for brain and spinal cord tumours.

Alternating electric fields therapy

Alternating electric fields therapy uses electricity to stop the tumour cells from dividing, which may prevent the tumour from growing or spreading quickly into the nearby brain tissues.

Alternating electric fields therapy may be offered to people with newly diagnosed glioblastoma.

Find out more about alternating electric fields therapy.

Corticosteriods and antiseizure medicines

Corticosteroids and antiseizure medicines (anticonvulsants) may be offered to help lessen the symptoms caused by glioblastoma and treatment side effects.

Find out more about corticosteroids and antiseizure medicines.

Recurrent glioblastoma

Recurrent glioblastoma means that the cancer has come back after being treated. Glioblastoma often recurs within 2 years after being treated.

Treatment options for recurrent glioblastoma include:

  • surgery – if the tumour can be removed safely and without any significant neurological effects
  • stereotactic radiation therapy
  • chemotherapy with temozolomide or PCV (procarbazine, lomustine and vincristine)
  • immunotherapy with bevacizumab (Avastin and biosimilars) combined with lomustine
  • alternating electric fields therapy

If you can’t have or don’t want cancer treatment

You may want to consider a type of care to make you feel better without treating the cancer itself. This may be because the cancer treatments don’t work anymore, they’re not likely to improve your condition or they may cause side effects that are hard to cope with. There may also be other reasons why you can’t have or don't want cancer treatment.

Talk to your healthcare team. They can help you choose care and treatment for advanced cancer.

Clinical trials

Talk to your doctor about clinical trials open to people with brain and spinal cord tumours in Canada. Clinical trials look at new ways to prevent, find and treat cancer. Find out more about clinical trials.

Expert review and references

  • Bao J, Pan Z, Wei S. Intital tratment of IDH-wildtype glioblastoma in adults older than 70 years. Cureus. 2023: 15(10):e47602.
  • Miller JJ. Targeting IDH-mutant glioma. Neurotherapeutics. 2022: 19(6): 1724–1732.
  • Mitchell D, Shireman JM, Dey M. Surgical neuro-oncology: management of glioma. Neurology Clinics. 2022: 40(2): 437–453.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Central Nervous System Cancers Version 4.2024. 2025. https://www.nccn.org/home.
  • Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults. JAMA. 2023: 329(7): 574–587.
  • Smolarska A, Pruszynska I, Wasylko W, Godlewska K, Markowska M, Rybak A, et al. Targeted therapies for glioblastoma treatment. Journal of Physiology and Pharmacology. 2023: 74(3): 251–261.
  • Van den Bent MJ, French PJ, Brat D, Tonn JC, Touat M, Ellingson BM, et al.. The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?. Neuro-oncology. 2024: 26(10): 1805–1822.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2026 Canadian Cancer Society